Midtrimester Abortion Using Prostaglandin F2α, Oxytocin, and Laminaria**Supported by The Upjohn Company, Kalamazoo, Michigan.††Presented at the Twenty-Ninth Annual Meeting of The American Fertility Society, April 5–7, 1973, San Francisco, California.
- 1 August 1973
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 24 (8), 565-568
- https://doi.org/10.1016/s0015-0282(16)39848-x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Oxytocin administration in mid-trimester saline abortionsAmerican Journal of Obstetrics and Gynecology, 1973
- Midtrimester abortion produced by intra-amniotic prostaglandin F2α augmented with intravenous oxytoxinAmerican Journal of Obstetrics and Gynecology, 1972
- Cervical FistulaObstetrics & Gynecology, 1972
- Intravenous prostaglandin F2α for therapeutic abortionAmerican Journal of Obstetrics and Gynecology, 1972
- FURTHER STUDIES ON THE INTERACTION BETWEEN PROSTAGLANDINS AND SYNTOCINON ON THE ISOLATED PREGNANT HUMAN MYOMETRIUMBJOG: An International Journal of Obstetrics and Gynaecology, 1972